| Symbol |
Name |
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACTN1
|
actinin, alpha 1
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
ADAMTSL3
|
ADAMTS-like 3
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADM
|
adrenomedullin
|
|
ADORA1
|
adenosine A1 receptor
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADORA3
|
adenosine A3 receptor
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
|
AIRE
|
autoimmune regulator
|
|
AK7
|
adenylate kinase 7
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G)
|
|
ANKRD30A
|
ankyrin repeat domain 30A
|
|
ANXA1
|
annexin A1
|
|
ANXA2
|
annexin A2
|
|
ANXA4
|
annexin A4
|
|
APC
|
adenomatous polyposis coli
|
|
APOA1
|
apolipoprotein A-I
|
|
APOE
|
apolipoprotein E
|
|
APOL2
|
apolipoprotein L, 2
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP5
|
aquaporin 5
|
|
AR
|
androgen receptor
|
|
ARFRP1
|
ADP-ribosylation factor related protein 1
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ASIC1
|
acid sensing (proton gated) ion channel 1
|
|
ASIC2
|
acid sensing (proton gated) ion channel 2
|
|
ASIC3
|
acid sensing (proton gated) ion channel 3
|
|
ATOH1
|
atonal homolog 1 (Drosophila)
|
|
ATP6AP2
|
ATPase, H+ transporting, lysosomal accessory protein 2
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding
|
|
BARX1
|
BARX homeobox 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BDKRB1
|
bradykinin receptor B1
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BEST1
|
bestrophin 1
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BPIFA1
|
BPI fold containing family A, member 1
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BSG
|
basigin (Ok blood group)
|
|
C1QTNF5
|
C1q and tumor necrosis factor related protein 5
|
|
C6ORF89
|
chromosome 6 open reading frame 89
|
|
CA9
|
carbonic anhydrase IX
|
|
CADM3
|
cell adhesion molecule 3
|
|
CALD1
|
caldesmon 1
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP5
|
caspase 5, apoptosis-related cysteine peptidase
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCL14
|
chemokine (C-C motif) ligand 14
|
|
CCL15
|
chemokine (C-C motif) ligand 15
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL7
|
chemokine (C-C motif) ligand 7
|
|
CCL8
|
chemokine (C-C motif) ligand 8
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR9
|
chemokine (C-C motif) receptor 9
|
|
CD109
|
CD109 molecule
|
|
CD14
|
CD14 molecule
|
|
CD274
|
CD274 molecule
|
|
CD34
|
CD34 molecule
|
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex)
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD86
|
CD86 molecule
|
|
CD8A
|
CD8a molecule
|
|
CDC42
|
cell division cycle 42
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH17
|
cadherin 17, LI cadherin (liver-intestine)
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDX1
|
caudal type homeobox 1
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHRD
|
chordin
|
|
CHRM1
|
cholinergic receptor, muscarinic 1
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CLCA1
|
chloride channel accessory 1
|
|
CLDN2
|
claudin 2
|
|
CLDN3
|
claudin 3
|
|
CLDN4
|
claudin 4
|
|
CLDN5
|
claudin 5
|
|
CLU
|
clusterin
|
|
CMA1
|
chymase 1, mast cell
|
|
CMTM5
|
CKLF-like MARVEL transmembrane domain containing 5
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CNTF
|
ciliary neurotrophic factor
|
|
COL7A1
|
collagen, type VII, alpha 1
|
|
CRISP3
|
cysteine-rich secretory protein 3
|
|
CRNN
|
cornulin
|
|
CSE1L
|
CSE1 chromosome segregation 1-like (yeast)
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSL
|
cathepsin L
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYGB
|
cytoglobin
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP27A1
|
cytochrome P450, family 27, subfamily A, polypeptide 1
|
|
CYP2A13
|
cytochrome P450, family 2, subfamily A, polypeptide 13
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP7B1
|
cytochrome P450, family 7, subfamily B, polypeptide 1
|
|
CYSLTR1
|
cysteinyl leukotriene receptor 1
|
|
CYSLTR2
|
cysteinyl leukotriene receptor 2
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DAB2IP
|
DAB2 interacting protein
|
|
DAZ1
|
deleted in azoospermia 1
|
|
DCLK1
|
doublecortin-like kinase 1
|
|
DCT
|
dopachrome tautomerase
|
|
DEFB1
|
defensin, beta 1
|
|
DEFB103B
|
defensin, beta 103B
|
|
DEFB109
|
defensin, beta 109
|
|
DEFB4A
|
defensin, beta 4A
|
|
DHX58
|
DEXH (Asp-Glu-X-His) box polypeptide 58
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DIO1
|
deiodinase, iodothyronine, type I
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3
|
|
DKK4
|
dickkopf WNT signaling pathway inhibitor 4
|
|
DLL1
|
delta-like 1 (Drosophila)
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DNAJC5
|
DnaJ (Hsp40) homolog, subfamily C, member 5
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DRD2
|
dopamine receptor D2
|
|
DSG2
|
desmoglein 2
|
|
DUOX1
|
dual oxidase 1
|
|
DUOX2
|
dual oxidase 2
|
|
E2F1
|
E2F transcription factor 1
|
|
ECE1
|
endothelin converting enzyme 1
|
|
EDN1
|
endothelin 1
|
|
EFNA3
|
ephrin-A3
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EHF
|
ets homologous factor
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ENAH
|
enabled homolog (Drosophila)
|
|
ENO1
|
enolase 1, (alpha)
|
|
ENTPD2
|
ectonucleoside triphosphate diphosphohydrolase 2
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA2
|
EPH receptor A2
|
|
EPHB2
|
EPH receptor B2
|
|
EPO
|
erythropoietin
|
|
EPS8
|
epidermal growth factor receptor pathway substrate 8
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F11R
|
F11 receptor
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FABP6
|
fatty acid binding protein 6, ileal
|
|
FABP7
|
fatty acid binding protein 7, brain
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FBLN2
|
fibulin 2
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FCER1G
|
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGF9
|
fibroblast growth factor 9
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FHIT
|
fragile histidine triad
|
|
FHL1
|
four and a half LIM domains 1
|
|
FLG
|
filaggrin
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXA1
|
forkhead box A1
|
|
FOXP3
|
forkhead box P3
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1
|
|
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa)
|
|
GATA6
|
GATA binding protein 6
|
|
GCLC
|
glutamate-cysteine ligase, catalytic subunit
|
|
GCRG224
|
gastric cancer-related gene GCRG224
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GMNN
|
geminin, DNA replication inhibitor
|
|
GPX2
|
glutathione peroxidase 2
|
|
GREB1
|
growth regulation by estrogen in breast cancer 1
|
|
GRHL2
|
grainyhead-like 2 (Drosophila)
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
|
GSDMA
|
gasdermin A
|
|
GSDMB
|
gasdermin B
|
|
GSDMC
|
gasdermin C
|
|
GSDMD
|
gasdermin D
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
HADHA
|
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HES5
|
hes family bHLH transcription factor 5
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor
|
|
HIST1H2BK
|
histone cluster 1, H2bk
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HMOX2
|
heme oxygenase 2
|
|
HOXA10
|
homeobox A10
|
|
HOXB4
|
homeobox B4
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRH2
|
histamine receptor H2
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HVCN1
|
hydrogen voltage gated channel 1
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICAM2
|
intercellular adhesion molecule 2
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGH
|
immunoglobulin heavy locus
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL13
|
interleukin 13
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL19
|
interleukin 19
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL22
|
interleukin 22
|
|
IL32
|
interleukin 32
|
|
IL33
|
interleukin 33
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
IL9
|
interleukin 9
|
|
IL9R
|
interleukin 9 receptor
|
|
ILK
|
integrin-linked kinase
|
|
INSL5
|
insulin-like 5
|
|
INSR
|
insulin receptor
|
|
IRF3
|
interferon regulatory factor 3
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
JUN
|
jun proto-oncogene
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KDR
|
kinase insert domain receptor
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KL
|
klotho
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KLK4
|
kallikrein-related peptidase 4
|
|
KLK7
|
kallikrein-related peptidase 7
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT10
|
keratin 10, type I
|
|
KRT13
|
keratin 13, type I
|
|
KRT18
|
keratin 18, type I
|
|
KRT19
|
keratin 19, type I
|
|
KRT20
|
keratin 20, type I
|
|
KRT4
|
keratin 4, type II
|
|
KRT7
|
keratin 7, type II
|
|
KRT8
|
keratin 8, type II
|
|
KSR1
|
kinase suppressor of ras 1
|
|
LACRT
|
lacritin
|
|
LAMA5
|
laminin, alpha 5
|
|
LCN1
|
lipocalin 1
|
|
LCT
|
lactase
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEP
|
leptin
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS7
|
lectin, galactoside-binding, soluble, 7
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5
|
|
LIF
|
leukemia inhibitory factor
|
|
LINC00575
|
long intergenic non-protein coding RNA 575
|
|
LMO4
|
LIM domain only 4
|
|
LOC645468
|
insulin-like growth factor 2 mRNA binding protein 3 pseudogene
|
|
LPO
|
lactoperoxidase
|
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1
|
|
LRIG2
|
leucine-rich repeats and immunoglobulin-like domains 2
|
|
LTF
|
lactotransferrin
|
|
LUM
|
lumican
|
|
LY6D
|
lymphocyte antigen 6 complex, locus D
|
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1
|
|
MAL
|
mal, T-cell differentiation protein
|
|
MAOA
|
monoamine oxidase A
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPKBP1
|
mitogen-activated protein kinase binding protein 1
|
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate
|
|
MAVS
|
mitochondrial antiviral signaling protein
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFGE8
|
milk fat globule-EGF factor 8 protein
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR137
|
microRNA 137
|
|
MIR143
|
microRNA 143
|
|
MIR145
|
microRNA 145
|
|
MIR155
|
microRNA 155
|
|
MIR184
|
microRNA 184
|
|
MIR200A
|
microRNA 200a
|
|
MIR200B
|
microRNA 200b
|
|
MIR205
|
microRNA 205
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR223
|
microRNA 223
|
|
MIR31
|
microRNA 31
|
|
MIR449A
|
microRNA 449a
|
|
MIR494
|
microRNA 494
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP20
|
matrix metallopeptidase 20
|
|
MMP28
|
matrix metallopeptidase 28
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPP5
|
membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5)
|
|
MS4A8
|
membrane-spanning 4-domains, subfamily A, member 8
|
|
MSH2
|
mutS homolog 2
|
|
MSH3
|
mutS homolog 3
|
|
MTAP
|
methylthioadenosine phosphorylase
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYO1A
|
myosin IA
|
|
MYO7A
|
myosin VIIA
|
|
MYOF
|
myoferlin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NES
|
nestin
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NGB
|
neuroglobin
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NGFR
|
nerve growth factor receptor
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NME9
|
NME/NM23 family member 9
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOG
|
noggin
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPC
|
natriuretic peptide C
|
|
NPS
|
neuropeptide S
|
|
NPSR1
|
neuropeptide S receptor 1
|
|
NPY
|
neuropeptide Y
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
OCLN
|
occludin
|
|
OPTC
|
opticin
|
|
OTX1
|
orthodenticle homeobox 1
|
|
OTX2
|
orthodenticle homeobox 2
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PADI2
|
peptidyl arginine deiminase, type II
|
|
PAK6
|
p21 protein (Cdc42/Rac)-activated kinase 6
|
|
PALLD
|
palladin, cytoskeletal associated protein
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX2
|
paired box 2
|
|
PAX8
|
paired box 8
|
|
PCA3
|
prostate cancer associated 3 (non-protein coding)
|
|
PCDH1
|
protocadherin 1
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PCSK5
|
proprotein convertase subtilisin/kexin type 5
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
|
PDE9A
|
phosphodiesterase 9A
|
|
PDPN
|
podoplanin
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PGLYRP1
|
peptidoglycan recognition protein 1
|
|
PHLDA1
|
pleckstrin homology-like domain, family A, member 1
|
|
PI3
|
peptidase inhibitor 3, skin-derived
|
|
PIGR
|
polymeric immunoglobulin receptor
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLEKHA7
|
pleckstrin homology domain containing, family A member 7
|
|
POU2F3
|
POU class 2 homeobox 3
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPIB
|
peptidylprolyl isomerase B (cyclophilin B)
|
|
PRDX3
|
peroxiredoxin 3
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRL
|
prolactin
|
|
PROCR
|
protein C receptor, endothelial
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER3
|
prostaglandin E receptor 3 (subtype EP3)
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTMA
|
prothymosin, alpha
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PVRL4
|
poliovirus receptor-related 4
|
|
PYY
|
peptide YY
|
|
QKI
|
QKI, KH domain containing, RNA binding
|
|
RAB13
|
RAB13, member RAS oncogene family
|
|
RAB27A
|
RAB27A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARG
|
retinoic acid receptor, gamma
|
|
RBP3
|
retinol binding protein 3, interstitial
|
|
REG1A
|
regenerating islet-derived 1 alpha
|
|
REG1B
|
regenerating islet-derived 1 beta
|
|
REG4
|
regenerating islet-derived family, member 4
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RGR
|
retinal G protein coupled receptor
|
|
RHOA
|
ras homolog family member A
|
|
RLBP1
|
retinaldehyde binding protein 1
|
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa
|
|
RRM2B
|
ribonucleotide reductase M2 B (TP53 inducible)
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A7
|
S100 calcium binding protein A7
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SCGB3A2
|
secretoglobin, family 3A, member 2
|
|
SCNN1A
|
sodium channel, non voltage gated 1 alpha subunit
|
|
SCNN1B
|
sodium channel, non voltage gated 1 beta subunit
|
|
SCNN1G
|
sodium channel, non voltage gated 1 gamma subunit
|
|
SCRIB
|
scribbled planar cell polarity protein
|
|
SDC1
|
syndecan 1
|
|
SDC4
|
syndecan 4
|
|
SELL
|
selectin L
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINB3
|
serpin peptidase inhibitor, clade B (ovalbumin), member 3
|
|
SERPINB4
|
serpin peptidase inhibitor, clade B (ovalbumin), member 4
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SFN
|
stratifin
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFTPA1
|
surfactant protein A1
|
|
SHH
|
sonic hedgehog
|
|
SIRT1
|
sirtuin 1
|
|
SIX1
|
SIX homeobox 1
|
|
SLC12A1
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 1
|
|
SLC14A1
|
solute carrier family 14 (urea transporter), member 1 (Kidd blood group)
|
|
SLC15A1
|
solute carrier family 15 (oligopeptide transporter), member 1
|
|
SLC15A2
|
solute carrier family 15 (oligopeptide transporter), member 2
|
|
SLC15A3
|
solute carrier family 15 (oligopeptide transporter), member 3
|
|
SLC15A4
|
solute carrier family 15 (oligopeptide transporter), member 4
|
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1
|
|
SLC16A4
|
solute carrier family 16, member 4
|
|
SLC17A9
|
solute carrier family 17 (vesicular nucleotide transporter), member 9
|
|
SLC19A2
|
solute carrier family 19 (thiamine transporter), member 2
|
|
SLC19A3
|
solute carrier family 19 (thiamine transporter), member 3
|
|
SLC26A6
|
solute carrier family 26 (anion exchanger), member 6
|
|
SLC26A9
|
solute carrier family 26 (anion exchanger), member 9
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A2
|
solute carrier family 2 (facilitated glucose transporter), member 2
|
|
SLC30A4
|
solute carrier family 30 (zinc transporter), member 4
|
|
SLC36A1
|
solute carrier family 36 (proton/amino acid symporter), member 1
|
|
SLC39A2
|
solute carrier family 39 (zinc transporter), member 2
|
|
SLC39A4
|
solute carrier family 39 (zinc transporter), member 4
|
|
SLC4A11
|
solute carrier family 4, sodium borate transporter, member 11
|
|
SLC5A1
|
solute carrier family 5 (sodium/glucose cotransporter), member 1
|
|
SLC5A2
|
solute carrier family 5 (sodium/glucose cotransporter), member 2
|
|
SLC6A6
|
solute carrier family 6 (neurotransmitter transporter), member 6
|
|
SLC7A1
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1
|
|
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SNAI1
|
snail family zinc finger 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SPAG11B
|
sperm associated antigen 11B
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPIB
|
Spi-B transcription factor (Spi-1/PU.1 related)
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPTSSB
|
serine palmitoyltransferase, small subunit B
|
|
SQSTM1
|
sequestosome 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
|
SST
|
somatostatin
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STXBP2
|
syntaxin binding protein 2
|
|
SYK
|
spleen tyrosine kinase
|
|
TAC1
|
tachykinin, precursor 1
|
|
TACR1
|
tachykinin receptor 1
|
|
TBP
|
TATA box binding protein
|
|
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor)
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TF
|
transferrin
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2)
|
|
TFF1
|
trefoil factor 1
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM2
|
transglutaminase 2
|
|
TH
|
tyrosine hydroxylase
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THRA
|
thyroid hormone receptor, alpha
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TJP1
|
tight junction protein 1
|
|
TLR1
|
toll-like receptor 1
|
|
TLR10
|
toll-like receptor 10
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR8
|
toll-like receptor 8
|
|
TLR9
|
toll-like receptor 9
|
|
TMEM26
|
transmembrane protein 26
|
|
TMIGD2
|
transmembrane and immunoglobulin domain containing 2
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP6
|
tumor necrosis factor, alpha-induced protein 6
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNKS
|
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase
|
|
TNXB
|
tenascin XB
|
|
TOLLIP
|
toll interacting protein
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPT1
|
tumor protein, translationally-controlled 1
|
|
TPX2
|
TPX2, microtubule-associated
|
|
TRAF4
|
TNF receptor-associated factor 4
|
|
TRIM21
|
tripartite motif containing 21
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TRPV5
|
transient receptor potential cation channel, subfamily V, member 5
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TSC22D1
|
TSC22 domain family, member 1
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TTPA
|
tocopherol (alpha) transfer protein
|
|
TUB
|
tubby bipartite transcription factor
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TULP1
|
tubby like protein 1
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UGT1A6
|
UDP glucuronosyltransferase 1 family, polypeptide A6
|
|
UGT2A1
|
UDP glucuronosyltransferase 2 family, polypeptide A1, complex locus
|
|
UGT2A2
|
UDP glucuronosyltransferase 2 family, polypeptide A2
|
|
UGT2A3
|
UDP glucuronosyltransferase 2 family, polypeptide A3
|
|
ULBP2
|
UL16 binding protein 2
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VIM
|
vimentin
|
|
VIP
|
vasoactive intestinal peptide
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
|
WDR19
|
WD repeat domain 19
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WNT7A
|
wingless-type MMTV integration site family, member 7A
|
|
YY1
|
YY1 transcription factor
|
|
ZFP36
|
ZFP36 ring finger protein
|
|
ZFYVE9
|
zinc finger, FYVE domain containing 9
|
